文献速递肝病

欧洲非酒精性脂肪性肝病公共卫生应对的横断面研究

A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe.
PubMed 文献 · J Hepatol · 2019-09-10

该研究调查了29个欧洲国家的NAFLD专家,评估各国在政策、指南、意识、监测、诊断和临床评估方面的公共卫生应对。结果显示,没有国家制定书面战略或行动计划,仅部分国家有临床指南、筛查推荐、转诊流程、生活方式项目、意识宣传活动、民间社会团体或国家登记。结论是欧洲国家缺乏对NAFLD的全面公共卫生应对。

要点

  • 29个欧洲国家均无NAFLD书面战略或行动计划。
  • 仅34%国家有NAFLD国家临床指南,38%推荐对糖尿病、肥胖和/或代谢综合征患者筛查NAFLD。
  • 17%国家有初级保健转诊流程,24%有结构化生活方式项目或资助的意识宣传活动。

核心结论

  • 被调查的欧洲国家缺乏对NAFLD的全面公共卫生应对,包括战略、指南、意识宣传、民间社会和登记等方面。

研究设计与样本

  • 2018年和2019年,29个欧洲国家的NAFLD专家完成英文调查,内容涉及政策、指南、意识、监测、诊断和临床评估,数据经质量检查后描述性报告。

主要发现

  • 29个国家均无NAFLD书面战略或行动计划。
  • 2个国家(7%)在现有相关战略(肥胖和酒精)中提及NAFLD或NASH。
  • 10个国家(34%)报告有专门针对NAFLD的国家临床指南,诊断时均包含糖尿病和肝硬化评估推荐。
  • 5个国家(17%)有初级保健随访和专科转诊流程,7个国家(24%)有结构化生活方式项目,7个国家(24%)有资助的意识宣传活动,4个国家(14%)有民间社会团体,3个国家(10%)有包含NAFLD的国家登记。

关键数值与推荐

  • 2个国家(7%)在现有战略中提及NAFLD或NASH。
  • 10个国家(34%)有NAFLD国家临床指南。
  • 5个国家(17%)有初级保健转诊流程。
  • 7个国家(24%)有结构化生活方式项目,7个国家(24%)有资助的意识宣传活动,4个国家(14%)有民间社会团体,3个国家(10%)有国家登记。

临床怎么用

  • 提示欧洲各国在NAFLD公共卫生应对上存在显著差距,需加强国家战略、临床指南、筛查推荐、转诊流程、生活方式干预、意识宣传、民间社会参与和登记建设。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Non-alcoholic fatty liver disease (NAFLD) is a growing public health problem worldwide and has become an important field of biomedical inquiry. We aimed to determine whether European countries have mounted an adequate public health response to NAFLD and non-alcoholic steatohepatitis (NASH). METHODS: In 2018 and 2019, NAFLD experts in 29 European countries completed an English-language survey on policies, guidelines, awareness, monitoring, diagnosis and clinical assessment in their country. The data were compiled, quality checked against existing official documents and reported descriptively. RESULTS: None of the 29 participating countries had written strategies or action plans for NAFLD. Two countries (7%) had mentions of NAFLD or NASH in related existing strategies (obesity and alcohol). Ten (34%) reported having national clinical guidelines specifically addressing NAFLD and, upon diagnosis, all included recommendations for the assessment of diabetes and liver cirrhosis. Eleven countries (38%) recommended screening for NAFLD in all patients with either diabetes, obesity and/or metabolic syndrome. Five countries (17%) had referral algorithms for follow-up and specialist referral in primary care, and 7 (24%) reported structured lifestyle programmes aimed at NAFLD. Seven (24%) had funded awareness campaigns that specifically included prevention of liver disease. Four countries (14%) reported having civil society groups which address NAFLD and 3 countries (10%) had national registries that include NAFLD. CONCLUSIONS: We found that a comprehensive public health response to NAFLD is lacking in the surveyed European countries. This includes policy in the form of a strategy, clinical guidelines, awareness campaigns, civil society involvement, and health systems organisation, including registries. LAY SUMMARY: We conducted a survey on non-alcoholic fatty liver disease with experts in European countries, coupled with data extracted from official documents on policies, clinical guidelines, awareness, and monitoring. We found a general lack of national policies, awareness campaigns and civil society involvement, and few epidemiological registries.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Lazarus JV, Ekstedt M, Marchesini G, et al. A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe. J Hepatol. 2019. PMID: 31518646. doi:10.1016/j.jhep.2019.08.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。